Skip to main content
Clinical Trials/KCT0005460
KCT0005460
Not yet recruiting
未知

A Clinical Trial to Analyze the effect of oral intake of Phellinus linteus(sanghuang) Extract on immune function: Randomized, Double-blind Controlled Trial

Cheonan Korean Medicine Hospital of Daejeon University0 sites98 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Cheonan Korean Medicine Hospital of Daejeon University
Enrollment
98
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Cheonan Korean Medicine Hospital of Daejeon University

Eligibility Criteria

Inclusion Criteria

  • 1\. Men and women aged 20 to 65 years old
  • 2\. Peripheral blood WBC of 3×1000/µl or more and less than 10×1000/µl
  • 3\. Those who have had upper respiratory tract infections or cold symptoms, a typical disease that can cause upper respiratory tract infections, more than two times within one year before the start of the test
  • 4\. A person who has agreed to participate in this test and signed a written consent form by the subject (or legal representative) voluntarily

Exclusion Criteria

  • 1\. Those who are currently being treated for clinically significant acute or chronic cardio\-cerebrovascular system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, nervous system, musculoskeletal disease, psychotic, infectious and hematologic/neoplastic diseases, etc. You can participate in the research at the discretion of the research director considering the status of
  • 2\. Those with uncontrolled hypertension (160/100mmHg or more, measured after 10 minutes of rest for the subject)
  • 3\. Patients with uncontrolled diabetes (fasting glucose 126mg/dL or higher, or starting a new drug due to diabetes within 3 months)
  • 4\. Those whose AST(GOT) or ALT(GPT) blood level is 3 times or more than the normal upper limit of the relevant organ7,8,9
  • 5\. Creatinine blood levels exceeding 2\.4mg/dL for men and 1\.8mg/dL for women
  • 6\. Those who have consumed or are ingesting health functional foods that may affect immunity within 2 weeks before screening
  • 7\. Those who complain of severe gastrointestinal symptoms such as heartburn and indigestion
  • 8\. Pregnant, lactating or planning to become pregnant during the study period
  • 9\. Those who are sensitive or allergic to test food related foods
  • 10\. Those who plan to participate in other studies during this study

Outcomes

Primary Outcomes

Not specified

Similar Trials